ArticleDrug design, development and therapy2021

Cinobufagin Suppresses the Characteristics of Osteosarcoma Cancer Cells by Inhibiting the IL-6-OPN-STAT3 Pathway [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.